Follow up of patients after percutaneous coronary intervention in community / 中华全科医师杂志

ABSTRACT

Objective Objective To follow up patients after percutaneous coronary intervention ( PCI) in the community.Methods One hundred and eleven patients in Hudong community of Shanghai Pudong New Area , who underwent PCI from august 2014 to august 2016 were followed up.During the follow-up the gender, age, smoking history, drinking history, body mass index ( BMI ), main concomitant disease , drug treatment and health education were surveyed by face to face interview .Results There were 63 males and 48 females with an average age of 67.1 ±10.7 years;51.4%( 57/111 ) patients were overweighted , 9.0%( 10/111 ) were obese; 29.7%( 33/111 ) had family history of early-onset ischemic cardiovascular disease; 60.3%( 67/111 ) patients used aspirin , 36.4%( 16/44 ) patients with aspirin intolerance used clopidogre or tigriello replaced .Drug-coated stents were implanted in 104 patients , 33.7%(35/104) withdrew dual antiplatelet drugs in less than one year; 71.1% (79/111) patients used statins and 60.1% ( 48/79 ) of them LDL-C reached the standard .Sixty seven patients had myocardial infarction or coronary heart disease with heart failure , 49.3% ( 33/67 ) of whom treated with angiotensin converting enzyme inhibitors (ACEI) /angiotensin receptor blockers (ARB).Ninety five patients had acute coronary syndromes or coronary heart disease with heart failure , 43.2% ( 41/95 ) of whom used beta-blockers.Fifty five patients(45.9%)had hypertension, and the blood pressure was controlled successfully in 54.9%(28/51)of them.Fifty five patients(49.5%)had diabetes mellitus and the glycosylated hemoglobin (HbA1c)was <7%in 27.3%(15/55)of them.Seventeen patients (15.3%) received weight management guidance, 50.5%(56/111)) patients received guidance on proper diet , 50.5% (56/111) received guidance on medication and precautions , 80.1%( 90/111 ) patients received guidance on when to call emergency calls.Conclusions The follow-up analysis shows that the compliance rate of anticoagulation and lowering LDL-C drug use is low , and the treatment of concomitant diseases and health education are not satisfactory for patients after PCI in the community .